Exponent Q2 rev up 12% (ex-reimb), EPS $0.60 vs $0.52; raises FY guidance, boosts buyback by $50M

EXPONENT INC

Q2 revenues before reimbursements $148.9M (+12% YoY); net income $29.4M ($0.60 diluted EPS) vs $26.6M ($0.52).
EBITDA margin improved to 28.7% of rev before reimb vs 27.8% a year ago; utilization 74%.
Raises FY2026 guidance: rev before reimb growth 9-10%, EBITDA margin 27.8-28.1%.
Board declares $0.31 quarterly dividend (payable Sept 18) and adds $50M to share repurchase authorization.
Strong demand in AI-related user research, utility infrastructure, and reactive work in consumer/chemicals/transport.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.